EUVIMEDOdkrijte EUVIMED
CrossrefInformacijska kartica

Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon Cancer

Dea N.M. Jepsen, Marianne B. Jensen, Trine L. Grantzau, Astrid L.B. Bennedsen, Thomas T. Eriksen, Michael Bzorek, Ismail Gögenur, Anne-Marie K. Fiehn

Applied Immunohistochemistry & Molecular Morphology · 2026-11 · 34 (6) · 403-411

DOI: 10.1097/pai.0000000000001345 ↗
PovzetekBibliografski podatki

Povzetek

Programmed death-ligand 1 (PD-L1) is a predictive biomarker in various cancers. In colorectal cancer, PD-L1 expression evaluation is not part of the routine examination and standardized evaluation methods are lacking. This study aimed to examine inter-rater agreement in PD-L1 expression evaluation in patients with colon cancer (CC) using different manual scoring methods, and to compare the manual methods to a digital evaluation. Two pathologists evaluated 188 PD-L1-stained slides from patients with CC. The tumor proportion score (TPS) and immune cell score (ICS) were categorized as

Znanje, ki ustreza vašemu delu.

Od brezplačnega začetka in osebnega iskanja literature do celotnega paketa Research Suite.

Ogled tarif →

Ali so vključena vsa polna besedila založnikov?

Ne. Bibliografski zapisi, povzetki in celotna besedila so različne vsebine. Ali je celotno besedilo na voljo, je odvisno od vira, odprtega dostopa in vaših obstoječih licenc. Paket EUVIMED ne nadomešča dodatnih pravic založnikov.

Ogled tarif →